The United States vaccines market is poised to reach a value of more than US$ 26 billion by 2026.
The United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026 provides a comprehensive analysis of the fast-evolving, high-growth united states vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the united states vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2026.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026. The report provides clear insight into current and future developments of the united states vaccines market. The report also explores the detailed analysis of the leading 27 vaccine market assessments in the United States from 2015 to 2018 and forecasts to 2026. A comprehensive analysis has been done on market share with a percentage of the leading 27 vaccines. The report also details the latest information about the vaccine’s pricing trends and the regulatory framework of the United States vaccine market.
The major companies dominating this market for its products, services, and continuous product developments are:
- Sanofi Pasteur
- GlaxoSmithKline (GSK)
- Dynavax Technologies Corporation
The following 27 leading vaccines of the united states vaccines market are detailed with market size and seven-years forecast
- Prevnar/Prevnar 13
- Gardasil/Gardasil 9
- Flucelvax Quadrivalent
- Afluria Quadrivalent
- Pneumovax 23
- M-M-R II
- Recombivax HB